fred
The game is afoot
- Messages
- 400
Posted on Co-Cure.
http://listserv.nodak.edu/cgi-bin/wa.exe?A2=ind1009d&L=co-cure&T=0&F&S&P=4248
http://listserv.nodak.edu/cgi-bin/wa.exe?A2=ind1009d&L=co-cure&T=0&F&S&P=4248
From Suzy Chapman
28 September 2010
Circulated on behalf of a member of the public:
May be reposted
FoI request to Imperial College London ref XMRV serology test
Following Professor Myra McClure's statement (in the Q&A session of the 1st International XMRV Workshop ) that "We've now done the serology", a Freedom of Information request was submitted to Imperial College London on 10th September 2010 to identify whether they had developed a serology test for XMRV. This included the following.
(i) Confirmation of whether Imperial College London has developed a serology (anti-body) test for XMRV (xenotropic murine leukaemia-related virus).
(ii) If this test is for both ME (also known as CFS) and prostate cancer combined, or for just one of these diseases in isolation, or if there are separate tests for each of these diseases.
(iii) If this test detects anti-bodies to all MLVs (murine leukaemia related viruses) or just XMRV.
(iv) If this test is used for research purposes only or if it is available commercially or if there are plans to make it available commercially.
(v) If this test has been developed for specific research purposes within Imperial College London, or other research institution, and if these research purposes will be published (e.g. in a science journal or on the college website) and when.
(vi) How long the test has been in use (for research purposes or otherwise).
The following response was received on 27th September 2010.
"Further to your Freedom of Information request, Imperial College has not developed a serology (anti-body) test for XMRV and therefore the remaining questions (ii - vi) are not applicable."
----------------------
It is unclear, therefore, which/whose XMRV serology assay is being used by Professor McClure and, given that it has not been developed by the Imperial team itself, how they are able to vouch for its reliability. If the assay in question has been proven empirically to detect XMRV antibodies and, given the growing number of UK patients who are testing positive via the Whittemore Peterson Institute/National Cancer Institute's methods, Imperial's continued failure to detect the retrovirus implies that either they have a flawed sample cohort and/or (as discussed at the 1st International XMRV Workshop) they could be using contaminated test tubes.
----------------------
Suzy Chapman
[log in to unmask]
http://dxrevisionwatch.wordpress.com
http://meagenda.wordpress.com
http://twitter.com/MEagenda
http://www.facebook.com/MEagenda